Adderall information from trusted sources:
Adderall
A single-entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d, l-amphetamine aspartate monohydrate. ADDERALL is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Adderall
A single-entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d, l-amphetamine aspartate monohydrate. EACH TABLET CONTAINS: 5 mg7.5 mg10 mg12.5 mg15 mg20 mg30 mg Dextroamphetamine Saccharate, 1.25 mg, 1.875 mg, 2.5 mg, 3.125 mg, 3.75 mg, 5 mg, 7.5 mg, Amphetamine Aspartate Monohydrate, 1.25 mg, 1.875 mg, 2.5 mg, 3.125 mg, 3.75 mg, 5 mg, 7.5 mg, Dextroamphetamine Sulfate USP, 1.25 mg, 1.875 mg,...
Amphetamine and Dextroamphetamine
Amphetamine and dextroamphetamine combination belongs to the group of medicines called central nervous system (CNS) stimulants. It is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy (uncontrollable desire for sleep or sudden attacks of deep sleep) .
Adderall
Adderall is prescribed in the treatment of Attention Deficit Hyperactivity Disorder (ADHD), the condition in which a child exhibits a short attention span and becomes easily distracted, overly emotional, excessively active, and highly impulsive. It should be used as part of a broader treatment plan that includes psychological, educational, and social measures. An extended-release form of the drug, called Adderall XR, is available for once-daily treatment of ADHD.
Adderall
A single-entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d, l-amphetamine aspartate monohydrate.
Adderall
FDA ALERT [8/2005] Health Canada Announces Return of Adderall to the Canadian Market. Adderall will return to the Canadian market for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) (see alert of 2/09/05 below). The Canadian Product Monograph will be revised to include warnings about the misuse of Adderall and that Adderall generally should not be used in patients with structural cardiac abnormalities.
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
A single entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d, l-amphetamine aspartate. .
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate, Amphetamine Asparate Monohydrate, Dextroamphetamine Sulfate and, Amphetamine Sulfate Extended-Release Capsules is a once daily extended-release, single-entity amphetamine product. Dextroamphetamine Saccharate, Amphetamine Asparate Monohydrate, Dextroamphetamine Sulfate and, Amphetamine Sulfate Extended-Release Capsules combines the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d,l-amphetamine aspartate monohydrate. The Dextroamphetamine Saccharate, Amphetamine Asparate Monohydrate, Dextroamphetamine Sulfate and, Amphetamine Sulfate Extended-Release Capsules capsule contains two types of drug-containing beads designed to give a double-pulsed delivery of amphetamines, which prolongs the release of amphetamine from Dextroamphetamine Saccharate, Amphetamine Asparate Monohydrate, Dextroamphetamine Sulfate and, Amphetamine Sulfate Extended-Release Capsules compared to the conventional ADDERALL (immediate-release) tablet formulation. Dextroamphetamine Saccharate, Amphetamine Asparate Monohydrate, Dextroamphetamine Sulfate and, Amphetamine Sulfate Extended-Release Capsules is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).